Caplight Directory>Companies>Coultreon Biopharma-preview>Coultreon


Coultreon Biopharma

Coultreon Biopharma

Private
LeuvenHealthcare & Life Scienceshttps://www.coultreon.com/

Last Round

Series A

Apr 28, 2026

Total Funding Raised

$148.4M

Company Overview

Coultreon Biopharma is a biotechnology company that develops therapies targeting clinically-validated pathways across immunology and metabolic diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share

AI Layer

Application

Keywords

autoimmune diseasesSIK3 inhibitorprecision medicinesmall molecule drugsclinical-stage biotechimmunologysalt-inducible kinaseoral therapypsoriasis treatmentulcerative colitis treatmentdrug discoverydrug developmentAI drug discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Coultreon Biopharma Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Coultreon Biopharma Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series AApr 28, 2026
SeedApr 1, 2025
View all Funding Rounds

Coultreon Biopharma Investors

Notable investors and investment history

InvestorRounds
Balyasny Asset Management L.P.Series A
Finchley Healthcare VenturesSeries A
ForbionSeries A
Regeneron VenturesSeries A
Novo HoldingsSeries A
Galapagos NVSeries A, Seed
Longwood FundSeries A
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 28, 2026

    $125M round led by Novo Holdings and Sofinnova Investments

  • Apr 1, 2025

    $23M round led by Galapagos NV.

View all signals

Coultreon Biopharma Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Coultreon Biopharma Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Coultreon Biopharma's valuation, stock price, and market status.

Firmographic Details

HeadquartersLeuven
Year Founded2025
Last FundingApr 28, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.